Clinical Trial: A Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of AZD1613 in Healthy Participants.

U.S., May 31 -- ClinicalTrials.gov registry received information related to the study (NCT06995820) titled 'A Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of AZD1613 in Healthy Participants.' on May 28.

Brief Summary: The purpose of the study is to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and immunogenicity of AZD1613 in healthy participants, including Japanese and Chinese descent.

Study Start Date: June 06

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: AZD1613

AZD1613 will be administered as either SC injection or IV infusion on Day 1 in Part A and on Days 1, 29 and 57 in Part B of the study.

DRUG: Placebo

Placebo will be ...